Is there a role for surgery in stage IIIA NSCLC when there
is N2 disease?
§
It is clear that a subset of patients benefits from
surgery
§
However,
in part because of the heterogeneity of the
disease
,
identification
of such patients has been
extremely challenging
§
It is paramount
to involve the surgery team
in the
initial evaluation
§
surgery should be done in high-volume centers
§
thoracic surgeons
§
These factors have been associated with improved survival
Jeremic B Clin Lung cancer 2016; Albain K, Lancet 2009; Farjah F Ann Thorac Surg 2009